✦ LIBER ✦

Practical blood dendritic cell vaccination for immunotherapy of multiple myeloma

✍ Scribed by F. Vari; D. J. Munster; J. L. Hsu; T. R. Rossetti; S. M. Mahler; P. P. Gray; C. J. Turtle; R. L. Prue; D. N. J. Hart

Book ID: 108675958
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 169 KB
Volume: 143
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07346.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour cell/dendritic cell fusions as a

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma

✍ Noopur Raje; Teru Hideshima; Faith E. Davies; Dharminder Chauhan; Steven P. Treo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Optimizing dendritic cell-based immunoth

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients

✍ Qing Yi; Susann Szmania; John Freeman; Jianfei Qian; Nancy A. Rosen; Sanjaya Vis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Phase I/II study of vaccination with den

Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia

✍ H. Roddie; M. Klammer; C. Thomas; R. Thomson; A. Atkinson; A. Sproul; M. Waterfa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Closed system generation of dendritic ce

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

✍ M. Elias; J. van Zanten; G.A.P. Hospers; A. Setroikromo; M.A. de Jong; L.F.M.H. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

Dendritic cells (DC) used for clinical trials should be processed on a large scale conforming to current good manufacturing practice (cGMP) guidelines. The aim of this study was to develop a protocol for clinical grade generation of immature DC in a closed-system. Aphereses were performed with the C

Adjuvant IL-15 does not enhance the effi

Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma

✍ Erin Gatza; Craig Y. Okada 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 969 KB

Predictive factors for a successful mobi

Predictive factors for a successful mobilization of peripheral blood CD34+cells in multiple myeloma

✍ G. Perea; A. Sureda; R. Martino; A. Altés; C. Martínez; E. Cabezudo; B. Amill; G 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 41 KB